ENTITY
Beijing Tiantan Biological Products

Beijing Tiantan Biological Products (600161 CH)

73
Analysis
Health Care • China
Beijing Tiantan Biological Products Corporation Limited researches, develops, and commercializes biological products. The Company provides treatment for hepatitis and offers a line of vaccine products including hepatitis vaccines and rubella vaccines.
more
•21 Feb 2015 00:02

Opening of E-commerce Channel to Change China's Drug Market

Numerous press outlets report that China’s Food & Drug Administration (CFDA) will release regulations permitting online sales of...

Share
•12 Feb 2026 19:39

Quiddity Leaderboard CSI 300/​​500 Jun26: Flow Sizes Drop; Net Inflows Underperform Net Outflows

Net inflow names have continued to underperform net outflow names. The AUM tracking many China Mainland indices have decline sharply over the last...

Share
bullish•Piotech
•16 Jan 2026 17:20

Quiddity Leaderboard CSI 300/​​500 Jun26: Mega Flows; Some Large Individual Flow Names Too

CSI 300 and CSI 500 Jun26 index rebal events could see one-way flows of US$6.8bn and US$7.6bn respectively. There are many names with >US$100mn...

Share
•22 Jun 2025 09:58

China Healthcare Weekly (Jun.22) - CNPGC to Acquire Shuanglin, Thoughts on Zhou Liu Fu's IPO Pricing

CNPGC plan to acquire Pacific Shuanglin, bringing new M&A/privatization due to horizontal competition. Zhou Liu Fu's IPO is fairly priced, but...

Logo
616 Views
Share
•20 Jun 2025 18:10

Quiddity Leaderboard ChiNext & ChiNext 50 Dec25: ~US$600mn Collective One-Way Flows

We see US$366mn and US$231mn one-way flows for the ChiNext and ChiNext 50 rebalance events respectively. The ChiNext expected ADDs have strong...

Share
x